Naming the fees it does not charge
The home page states that its plans include comprehensive coaching and services with no hidden fees, membership costs, or lab charges. Naming the specific line items is what makes it usable: a reader can hold a seller to no membership costs in a way they cannot hold one to no hidden fees, which is a promise about surprises and therefore about nothing.
Fifty-five of the one hundred and fifty-eight sellers here state that no membership fee applies. Forty-two say nothing either way.
Three lanes, one of them oral
A product rail on the home page prices a compounded semaglutide injection, a compounded tirzepatide injection and an oral compounded semaglutide. The oral is priced at the same rate as the semaglutide injection.
All three are starting-at figures with no plan term. That is the standing weakness of this batch and this seller does nothing to distinguish itself on it.
The sentence that is not about this company
Its Terms carry a warning that other services will be governed by agreements with those entities even though the LevelsRx logo may appear on the portal or other sites. It is a reasonable thing for a white-labelled telehealth brand to say.
The identical sentence, differing only in the brand name, appears on an unrelated GLP-1 seller's terms page. So it is a paragraph from a shared template rather than a statement this company wrote about its own arrangements, and a reader should treat it as evidence about the template industry these brands are built on rather than as a specific disclosure.
The operating company itself is named plainly in the opening sentence of the Terms and again in a copyright contact block with a street address. No compounding pharmacy is named, no individual clinician is named, and no service area is published.
LevelsRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $150/mostarting at, per month, from the product rail on the seller’s own home page | September 2026source |
| Semaglutide (compounded-oral) | $150/mostarting at, per month; the seller prices its oral semaglutide identically to its injection | September 2026source |
| Tirzepatide (compounded) | $240/mostarting at, per month, from the product rail on the seller’s own home page | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See LevelsRx's current price →Good fit if
- Readers who want the membership and lab-fee questions answered by name rather than waved away.
- Buyers who want an oral semaglutide priced at the injection's rate.
Look elsewhere if
- Anyone who needs a plan term beside a price; all three figures are starting-at rates.
- Readers who want the compounding pharmacy or a clinician named, or a service-area list.
- People who read a bespoke-sounding legal warning as a statement about this particular business.
How this review was verified
- Re-read the home page and the terms and conditions on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Compared the logo-and-portals sentence against the terms page of another GLP-1 seller and found it verbatim on both, and recorded it here as template language on that basis.
- Read the membership statement off the sentence that names membership costs and lab charges specifically, rather than off a no-hidden-fees line.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.